WO2024079840A1 - 培養装置の制御方法、および細胞培養を伴う培養装置の制御方法 - Google Patents

培養装置の制御方法、および細胞培養を伴う培養装置の制御方法 Download PDF

Info

Publication number
WO2024079840A1
WO2024079840A1 PCT/JP2022/038171 JP2022038171W WO2024079840A1 WO 2024079840 A1 WO2024079840 A1 WO 2024079840A1 JP 2022038171 W JP2022038171 W JP 2022038171W WO 2024079840 A1 WO2024079840 A1 WO 2024079840A1
Authority
WO
WIPO (PCT)
Prior art keywords
culture
value
set value
function
control method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2022/038171
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
広行 曽根
裕之 浅田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi Ltd
Original Assignee
Hitachi Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Ltd filed Critical Hitachi Ltd
Priority to PCT/JP2022/038171 priority Critical patent/WO2024079840A1/ja
Priority to EP22962059.6A priority patent/EP4603573A1/en
Priority to KR1020257010092A priority patent/KR20250056246A/ko
Priority to CN202280100382.8A priority patent/CN119948146A/zh
Priority to JP2024550991A priority patent/JPWO2024079840A1/ja
Priority to TW112139119A priority patent/TWI876587B/zh
Publication of WO2024079840A1 publication Critical patent/WO2024079840A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48—Automatic or computerized control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/12—Means for regulation, monitoring, measurement or control, e.g. flow regulation of temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/26—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
    • C12M41/34—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of gas

Definitions

  • the present invention relates to a method for controlling a culture device and a method for controlling a culture device involving cell culture.
  • Products produced by culture include cosmetics and medicines such as antibodies.
  • products produced by culture include cosmetics and medicines such as antibodies.
  • cells that have been engineered with genes that produce antibodies are cultured, and the antibodies secreted by the cultured cells are purified to produce the antibody drug.
  • Some of the products produced through such cultivation are of high quality and require urgent supply to the market.
  • downstream processes can be controlled based on information from the purification and concentration processes monitored in real time.
  • the present invention was made based on the above circumstances, and its purpose is to provide a method for controlling a culture device that enables culture to be performed in a more suitable culture environment, and a method for controlling a culture device that involves cell culture.
  • a control method for a culture apparatus comprising inputting a setting value for setting a culture environment to control the culture apparatus, A first step of acquiring an actual measurement value of the culture environment at the set value and an analysis value of the culture solution obtained by culturing at a predetermined timing; A second step of deriving a function for determining new set values for resetting the culture environment by machine learning using the actual measured values and analysis values obtained at the predetermined timing; and a third step of calculating a new set value based on a desired target value of the culture solution using the function, and inputting the new set value to perform culture.
  • the control method is characterized in that the function used in the third step is a new function derived from time to time by machine learning, including the latest actual measurement values and analysis values obtained at a predetermined timing.
  • the present disclosure also includes a control method for a culture device involving cell culture, the control method being used in the manufacture of biopharmaceuticals involving cell culture.
  • culture means growing a single cell or microorganism (a single-celled or multicellular organism) in a culture medium.
  • Continuous renewal includes both the concept of continuous renewal (renewal in real time) and the concept of intermittent renewal at specified intervals.
  • the present invention can provide a method for controlling a culture device that enables culture to be performed in a more suitable culture environment, and a method for controlling a culture device that involves cell culture.
  • FIG. 1 is a schematic process diagram showing an example of a manufacturing process for producing an antibody pharmaceutical using a continuous cell culture apparatus.
  • FIG. 1 is a schematic diagram showing an example of a continuous cell culture apparatus.
  • FIG. 13 is a schematic diagram showing a control method of the culture device in one embodiment.
  • FIG. 1 is a schematic diagram showing an example of a continuous cell culture apparatus.
  • FIG. 1 is a schematic process diagram showing an example of a manufacturing process for producing an antibody pharmaceutical using a batch culture apparatus.
  • the control method for a culture device disclosed herein is a control method for a culture device that controls a culture device that performs culture by inputting a setting value that sets a culture environment, and includes a first step of acquiring, at a predetermined timing, an actual measurement value of the culture environment at the set value and an analysis value of the culture solution obtained by culturing, a second step of deriving, by machine learning, a function for determining a new setting value for resetting the culture environment using the actual measurement value and analysis value acquired at the predetermined timing, and a third step of using the function to determine a new setting value based on a desired target value of the culture solution, and inputting this new setting value to perform culture, wherein the function used in the third step is a new function derived at any time by machine learning, including the latest actual measurement value and analysis value acquired at the predetermined timing.
  • control method for the culture device will be described as an example of a control method for a cell culture device that cultures cells.
  • a control method for a cell culture device can be used, for example, to control a cell culture device that cultures cells to produce pharmaceuticals such as antibodies.
  • a continuous cell culture device is exemplified as the cell culture device.
  • medium is continuously supplied to a culture system while an equal amount of culture liquid is simultaneously extracted from the culture system.
  • control method of the culture device described below is not limited to the control of the cell culture device.
  • one embodiment of the present invention will be described with reference to the drawings, but the present invention is not limited to the embodiment shown in the drawings.
  • FIG. 1 is a schematic diagram showing an example of a manufacturing process for producing an antibody drug using a continuous cell culture device.
  • an antibody drug substance can be produced, for example, by carrying out a culture process P1 and a purification process P2 in this order.
  • the culture process P1 is a process for culturing (growing) cells.
  • the culture process P1 is performed by controlling the continuous cell culture apparatus.
  • the continuous cell culture apparatus 1 can be composed of, for example, a continuous cell culture tank 100, a medium addition device 200, a cell separation device 300, a culture environment adjustment device 400, a control device 500, and a culture fluid analysis device 600.
  • the continuous cell culture vessel 100 cultures cells in a culture solution c under a specific culture environment.
  • the sensors 101, 102 and the culture solution analyzer 600 provided in the continuous cell culture vessel 100 measure actual values PV (Process Variables) and analytical values AV (Analytical Variables) described below.
  • the culture medium addition device 200 stores fresh culture medium and supplies this culture medium to the continuous cell culture vessel 100.
  • the cell separation device 300 separates the culture solution and cells with a membrane and extracts only the culture solution.
  • the culture environment adjustment device 400 adjusts the culture environment of the culture solution c, such as the temperature, pH, and dissolved oxygen concentration.
  • the control device 500 controls the continuous cell culture vessel 100, the culture medium addition device 200, the cell separation device 300, the culture environment adjustment device 400, etc. Details of the control device 500 will be described later.
  • the set value SV (Set Variable) is a variable that sets the culture environment of the continuous cell culture tank 100.
  • the set value SV is composed of one or more parameters. Examples of the parameters include the supply rate of the medium, the temperature of the culture fluid in the continuous cell culture tank 100, pH, dissolved oxygen concentration, the stirring speed of the culture fluid, and the perfusion rate.
  • the continuous cell culture device 1 is provided with a temperature regulator for adjusting the temperature of the culture fluid c, a pH regulator for adjusting the pH of the culture fluid c, an oxygen concentration regulator for adjusting the dissolved oxygen concentration in the culture fluid c, an agitator for uniformly stirring the culture fluid c, and a perfusion device for perfusing the culture fluid c, which are not shown.
  • the purification process P2 is a process for purifying specific products secreted from cells (biologically active substances, useful proteins such as antibodies, etc.) by separating other unnecessary substances (cell shells, viruses, products secreted from cells such as lactic acid and ammonia, etc.) so that the product has a specified quality.
  • the purification device (method) used is not particularly limited as long as it can separate a specific product.
  • the purification device include a continuous capture device, a virus inactivation device, and a filtration sterilization device as shown in Figure 1, as well as a gravity settling device, an ultrasonic aggregation device, a filtration separation device, and the like (not shown). In the purification step P2, these purification devices are used alone or in combination.
  • the control method for the continuous cell culture apparatus 1 controls the continuous cell culture apparatus 1 by inputting a set value SV that sets the culture environment. As shown in FIG. 3, the control method for the continuous cell culture apparatus 1 in this embodiment includes a first step S1, a second step S2, and a third step S3.
  • the first step S1 is a step of acquiring an actual measurement value PV of the culture environment at a set value SV and an analysis value AV of the culture solution c obtained by culturing at a predetermined timing.
  • the first step S1 is executed by measuring the actual measurement value PV and the analysis value AV by the sensors 101, 102, the culture solution analyzer 600, etc.
  • the actual measurement value PV of the culture environment (temperature, pH, pressure, dissolved oxygen concentration, dissolved carbon dioxide concentration, culture solution volume, etc. of the culture solution c) in the continuous cell culture apparatus 1 operated under a culture environment with a preset set value SV (hereinafter also referred to as the "existing set value SV") is acquired using the sensor 101, etc.
  • the analysis value AV which is an index of quality and productivity (number of live cells, antibody concentration, impurity concentration, etc.) of the culture solution c cultured by applying the existing set value SV, is acquired using the sensor 102, the culture solution analyzer 600, etc.
  • the timing (hereinafter also referred to as the "predetermined timing") at which the actual measurement value PV and the analysis value AV are acquired (actual measurement) may be continuous “constantly” or intermittent “timely”. Also, the actual measurement value PV and the analysis value AV may be acquired at the same timing or at different timings.
  • the second step S2 is a step of deriving a function F for determining a new set value SV for resetting the culture environment by machine learning using the actual measured value PV and the analysis value AV obtained at a predetermined timing.
  • the second step S2 is executed by a database 501, a data extraction unit 502, and a machine learning unit 503 of the control device 500 described later.
  • a function F for calculating a new set value SV is derived through machine learning using the actual measured values PV and analysis values AV obtained in the first step S1, which serve as training data.
  • Machine learning includes, for example, Bayesian estimation, support vector regression, random forest regression, and neural networks.
  • machine learning be performed using Bayesian estimation or support vector regression.
  • Bayesian estimation or support vector regression By applying Bayesian estimation or support vector regression to machine learning, a more accurate function F can be derived from the relatively small amount of training data, i.e., actual measured values PV and analysis values AV.
  • Such learning methods using Bayesian estimation or support vector regression are particularly effective in the case of limited samples during process development (situations in which there is little data available, such as actual measured values PV and analysis values AV), and in situations where there is an urgent need to supply pharmaceuticals to the market.
  • the third step S3 is a step of using the function F to determine a new set value SV based on a target variable TV (Target Variable) of the desired culture solution c, and inputting the new set value SV to the continuous cell culture apparatus 1 to perform culture.
  • the third step S3 is executed by a set value calculation unit 504 (described later) of the control device 500, the continuous cell culture tank 100, the culture medium addition device 200, the cell separation device 300, and the culture environment adjustment device 400.
  • a new set value SV is calculated using the desired target value TV of the culture solution c and the function F derived in the second step S2.
  • the target value TV of the desired culture solution c is an index related to quality and productivity (number of viable cells, antibody concentration, impurity concentration, etc.).
  • the new set value SV may be determined to be a value within a predetermined range. Specifically, for example, conditions such as the culture environment in which the continuous cell culture apparatus 1 is operated (the setting range of each parameter to be observed) may be determined in advance. In such a case, if the new set value SV calculated using the function F is a value outside the above-mentioned setting range, the new set value SV calculated using the function F may be corrected so that it falls within the above-mentioned setting range, and the corrected value may be used as the new set value SV. This makes it possible to culture cells under, for example, the manufacturing conditions of an approved pharmaceutical product.
  • the calculated new set value SV is input to the continuous cell culture apparatus 1, and the culture fluid c is cultured in the culture environment of the continuous cell culture apparatus 1 operated using this new set value SV.
  • the culture fluid c is cultured in the new culture environment. Note that when the values of the parameters constituting the existing set value SV and the new set value SV are the same, the parameters are maintained at the same values.
  • a new function F derived from time to time by machine learning including the latest measured value PV and the latest analysis value AV obtained at a predetermined timing is used as the function F used in the third step S3. That is, in the third step S3, the latest function F updated from time to time based on the latest information on the culture solution c is used, and a new set value SV is calculated using the latest function F.
  • the function F may be updated to a new function at the same timing as the specified timing at which the actual measured value PV and analysis value AV described above are obtained (continuous “always” or intermittent "timely"), or at a timing different from the specified timing.
  • the culture solution c can be cultured in a culture environment with a new set value SV obtained using the latest actual measured value PV and the latest analysis value AV.
  • control device 500 of the continuous cell culture device 1 can be composed of, for example, a database 501, a data extraction unit 502, a machine learning unit 503, and a set value calculation unit 504.
  • Database 501 stores data such as the set value SV, the actual measured value PV and analysis value AV obtained at a specified timing, and other lot and process information.
  • the data extraction unit 502 extracts data stored in the database 501 at appropriate times to be used by the machine learning unit 503 and the setting value calculation unit 504, which will be described later.
  • the machine learning unit 503 is a part that executes step S2.
  • the machine learning unit 503 uses the actual measured values PV and analysis values AV acquired from the database 501 via the data extraction unit 502 to perform machine learning to derive a function F for determining a new set value SV for resetting the culture environment.
  • the actual measured values PV and analysis values AV that serve as training data when performing machine learning may include the latest actual measured values PV and the latest analysis values AV.
  • a more accurate function F can be derived by machine learning using more training data including the latest information.
  • the set value calculation unit 504 is a part that calculates a new set value SV in step S3.
  • the set value calculation unit 504 uses the function F derived by the machine learning unit 503 to calculate a new set value SV based on the target value TV of the desired culture solution c.
  • Information (values) of each parameter included in the new set value SV calculated by the set value calculation unit 504 is sent to the continuous cell culture tank 100, the culture medium addition device 200, the cell separation device 300, and the culture environment adjustment device 400.
  • the above-mentioned control device 500 can be configured, for example, by the following hardware. That is, the database 501 is configured by a storage device that stores various data.
  • the storage device can be configured by any type of storage medium, and may include, for example, a semiconductor memory, a hard disk drive, etc.
  • the data extraction unit 502, the machine learning unit 503, and the setting value calculation unit 504 can be configured by a central processing unit (CPU) or the like that can execute the above-mentioned processes.
  • CPU central processing unit
  • the function F used in the third step S3 is a new function F derived at any time by machine learning including the latest actual measurement values PV and analysis values AV obtained at a specified timing, so that a more accurate new set value SV can be obtained by machine learning using more teacher data including the latest information, and culture can be performed in a more suitable culture environment. As a result, products with the desired quality and productivity can be reliably manufactured.
  • the control method of a culture apparatus involving cell culture of the present disclosure is characterized in that the control method of the culture apparatus described above in the section ⁇ Control method of a culture apparatus> is used in the production of biopharmaceuticals involving cell culture.
  • control method for the culture apparatus of the present disclosure allows cells to be cultured in a more suitable culture environment, and allows biopharmaceuticals such as antibody drugs to be produced with high quality and high productivity. Therefore, the control method for the culture apparatus of the present disclosure can be suitably applied to a control method for a culture apparatus involving cell culture, which is used in the production of biopharmaceuticals involving cell culture.
  • control method for a continuous cell culture apparatus 1 that produces antibody pharmaceuticals has been described as an example of a control method for a culture apparatus.
  • the control method for a culture apparatus disclosed herein can also be applied to the culture of other organisms than cells, so long as they can be grown by culture.
  • the control method for a culture apparatus disclosed herein can also be applied to a control method for a culture apparatus that produces cosmetics and the like by culturing microorganisms, such as single-celled organisms or multicellular organisms.
  • the continuous culture apparatus 1 has been described as an example of a culture apparatus to which the control method of the culture apparatus is applied.
  • the control method of the culture apparatus of the present disclosure may also be applied to a control method of a culture apparatus that performs batch processing (batch-type culture apparatus) as shown in FIG. 5 (FIG. 5 illustrates a manufacturing process of a biopharmaceutical drug substance using a batch-type cell culture apparatus).
  • batch-type culture apparatus illustrates a manufacturing process of a biopharmaceutical drug substance using a batch-type cell culture apparatus.
  • set values, actual measured values, analysis values, target values, and functions can be handled in the same way as in the continuous culture apparatus.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Computer Hardware Design (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PCT/JP2022/038171 2022-10-13 2022-10-13 培養装置の制御方法、および細胞培養を伴う培養装置の制御方法 Ceased WO2024079840A1 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PCT/JP2022/038171 WO2024079840A1 (ja) 2022-10-13 2022-10-13 培養装置の制御方法、および細胞培養を伴う培養装置の制御方法
EP22962059.6A EP4603573A1 (en) 2022-10-13 2022-10-13 Method for controlling culture device, and method for controlling culture device in association with cell culture
KR1020257010092A KR20250056246A (ko) 2022-10-13 2022-10-13 배양 장치의 제어 방법, 및 세포 배양을 수반하는 배양 장치의 제어 방법
CN202280100382.8A CN119948146A (zh) 2022-10-13 2022-10-13 培养装置的控制方法以及伴随细胞培养的培养装置的控制方法
JP2024550991A JPWO2024079840A1 (https=) 2022-10-13 2022-10-13
TW112139119A TWI876587B (zh) 2022-10-13 2023-10-13 培養裝置之控制方法、及伴隨細胞培養之培養裝置之控制方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2022/038171 WO2024079840A1 (ja) 2022-10-13 2022-10-13 培養装置の制御方法、および細胞培養を伴う培養装置の制御方法

Publications (1)

Publication Number Publication Date
WO2024079840A1 true WO2024079840A1 (ja) 2024-04-18

Family

ID=90669193

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/038171 Ceased WO2024079840A1 (ja) 2022-10-13 2022-10-13 培養装置の制御方法、および細胞培養を伴う培養装置の制御方法

Country Status (6)

Country Link
EP (1) EP4603573A1 (https=)
JP (1) JPWO2024079840A1 (https=)
KR (1) KR20250056246A (https=)
CN (1) CN119948146A (https=)
TW (1) TWI876587B (https=)
WO (1) WO2024079840A1 (https=)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019522802A (ja) 2016-04-04 2019-08-15 ベーリンガー インゲルハイム エルツェーファウ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 製剤精製のリアルタイムモニタリング
WO2020021860A1 (ja) * 2018-07-24 2020-01-30 富士フイルム株式会社 細胞培養支援装置の作動プログラム、細胞培養支援装置、細胞培養支援装置の作動方法
WO2020039683A1 (ja) * 2018-08-22 2020-02-27 富士フイルム株式会社 細胞培養支援装置の作動プログラム、細胞培養支援装置、細胞培養支援装置の作動方法
WO2020148956A1 (ja) * 2019-01-18 2020-07-23 富士フイルム株式会社 細胞生成支援装置、方法、及びプログラム
JP2021016359A (ja) * 2019-07-22 2021-02-15 株式会社カネカ 情報処理装置、細胞培養システム、情報処理方法、及びコンピュータプログラム
WO2022181049A1 (ja) * 2021-02-24 2022-09-01 ソニーグループ株式会社 細胞処理システム、細胞処理方法、学習データ作成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI583788B (zh) * 2011-09-16 2017-05-21 安美基公司 細胞培養之預程式化無回饋控制之連續進料
US20170260492A1 (en) * 2016-03-08 2017-09-14 Tokitae Llc Temperature stabilized culture incubator
US20190352589A1 (en) * 2018-05-18 2019-11-21 Huacells Corporation Automated Cell Culturing

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019522802A (ja) 2016-04-04 2019-08-15 ベーリンガー インゲルハイム エルツェーファウ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 製剤精製のリアルタイムモニタリング
WO2020021860A1 (ja) * 2018-07-24 2020-01-30 富士フイルム株式会社 細胞培養支援装置の作動プログラム、細胞培養支援装置、細胞培養支援装置の作動方法
WO2020039683A1 (ja) * 2018-08-22 2020-02-27 富士フイルム株式会社 細胞培養支援装置の作動プログラム、細胞培養支援装置、細胞培養支援装置の作動方法
WO2020148956A1 (ja) * 2019-01-18 2020-07-23 富士フイルム株式会社 細胞生成支援装置、方法、及びプログラム
JP2021016359A (ja) * 2019-07-22 2021-02-15 株式会社カネカ 情報処理装置、細胞培養システム、情報処理方法、及びコンピュータプログラム
WO2022181049A1 (ja) * 2021-02-24 2022-09-01 ソニーグループ株式会社 細胞処理システム、細胞処理方法、学習データ作成方法

Also Published As

Publication number Publication date
CN119948146A (zh) 2025-05-06
EP4603573A1 (en) 2025-08-20
JPWO2024079840A1 (https=) 2024-04-18
KR20250056246A (ko) 2025-04-25
TWI876587B (zh) 2025-03-11
TW202415760A (zh) 2024-04-16

Similar Documents

Publication Publication Date Title
US11774287B2 (en) Raman spectroscopy integrated perfusion cell culture system for monitoring and auto-controlling perfusion cell culture
Todaro et al. Fermentation and biochemical engineering handbook
CN112662551B (zh) 一种细胞培养控制方法以及系统
CN102391995B (zh) 一种杂交瘤细胞无血清高密度悬浮灌流培养工艺
CN103649299B (zh) 生产过程的监控系统及其控制方法
Chong et al. Robust on-line sampling and analysis during long-term perfusion cultivation of mammalian cells
CN110462018A (zh) 用于控制生物技术过程的方法
JP2025134848A (ja) 接種物を生産するためのプロセスおよびシステム
AU2018326894B2 (en) Production device, system, and method
JP2026505729A (ja) 少なくとも１つのバイオリアクタの代謝速度および環境因子を制御および監視するコンピュータベースのシステムおよびその使用方法
WO2024079840A1 (ja) 培養装置の制御方法、および細胞培養を伴う培養装置の制御方法
CN117625389A (zh) 细胞培养系统及细胞培养方法
Winder et al. The use of continuous culture in systems biology investigations
JP2020005511A (ja) 培養方法及び培養装置
Tan et al. Microtiter miniature shaken bioreactor system as a scale-down model for process development of production of therapeutic alpha-interferon2b by recombinant Escherichia coli
WO2018173463A1 (ja) 細胞培養装置の評価方法及び評価プログラム
Paim et al. Process system engineering methodologies applied to tissue development and regenerative medicine
Akram Culturing of Animal Cells, Stem Cells, Tissues, and Organs for Industrial Products: An Introduction
Gustavsson Development of soft sensors for monitoring and control of bioprocesses
EP4692296A1 (en) Cell culture device, culture conditions determination device, and culture conditions determination method
CN115768868A (zh) 用于疫苗生产的方法和系统
Suttle et al. A Beginner’s Guide to CHO Culture: Bioprocess Modes–Batch, Fed-Batch, and Perfusion
LT6395B (lt) Mikroorganizmų augimo greičio automatinė valdymo sistema ir būdas
HK40104952A (zh) 利用人工智能确定细胞培养条件的装置及装置的操作方法
Randek Advancement of sensor technology for monitoring and control of upstream bioprocesses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22962059

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 202280100382.8

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 20257010092

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 202517032372

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2024550991

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 1020257010092

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 202280100382.8

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2022962059

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022962059

Country of ref document: EP

Effective date: 20250513

WWP Wipo information: published in national office

Ref document number: 202517032372

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: 2022962059

Country of ref document: EP